FBXW12
gene geneOn this page
Also known as Fbw12
Summary
FBXW12 (F-box and WD repeat domain containing 12, HGNC:20729) is a protein-coding gene on chromosome 3p21.31, encoding F-box/WD repeat-containing protein 12 (Q6X9E4). Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex.
Members of the F-box protein family, such as FBXW12, are characterized by an approximately 40-amino acid F-box motif. SCF complexes, formed by SKP1 (MIM 601434), cullin (see CUL1; MIM 603034), and F-box proteins, act as protein-ubiquitin ligases. F-box proteins interact with SKP1 through the F box, and they interact with ubiquitination targets through other protein interaction domains (Jin et al., 2004 [PubMed 15520277]).
Source: NCBI Gene 285231 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 72 total
- MANE Select transcript:
NM_207102
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20729 |
| Approved symbol | FBXW12 |
| Name | F-box and WD repeat domain containing 12 |
| Location | 3p21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Fbw12 |
| Ensembl gene | ENSG00000164049 |
| Ensembl biotype | protein_coding |
| OMIM | 609075 |
| Entrez | 285231 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000296438, ENST00000415155, ENST00000436231, ENST00000445170, ENST00000468158, ENST00000477542
RefSeq mRNA: 3 — MANE Select: NM_207102
NM_001159927, NM_001159929, NM_207102
CCDS: CCDS2764, CCDS54577, CCDS54578
Canonical transcript exons
ENST00000296438 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001367820 | 48373548 | 48373705 |
| ENSE00001372687 | 48381700 | 48381878 |
| ENSE00001372875 | 48373308 | 48373345 |
| ENSE00001382345 | 48372684 | 48372857 |
| ENSE00001385993 | 48381955 | 48382085 |
| ENSE00001409694 | 48394560 | 48394725 |
| ENSE00002720728 | 48372219 | 48372320 |
| ENSE00003544399 | 48379400 | 48379558 |
| ENSE00003590194 | 48380702 | 48380912 |
| ENSE00003604134 | 48375354 | 48375472 |
| ENSE00003684616 | 48378317 | 48378526 |
Expression profiles
Bgee: expression breadth ubiquitous, 126 present calls, max score 80.39.
Top tissues by expression
232 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 80.39 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.71 | silver quality |
| pancreas | UBERON:0001264 | 65.51 | gold quality |
| ventricular zone | UBERON:0003053 | 62.15 | gold quality |
| cerebellar cortex | UBERON:0002129 | 58.73 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 58.73 | gold quality |
| right uterine tube | UBERON:0001302 | 58.45 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 58.16 | gold quality |
| cerebellum | UBERON:0002037 | 57.46 | gold quality |
| right frontal lobe | UBERON:0002810 | 55.41 | gold quality |
| amygdala | UBERON:0001876 | 54.80 | gold quality |
| prefrontal cortex | UBERON:0000451 | 54.62 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 54.59 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 54.19 | gold quality |
| nucleus accumbens | UBERON:0001882 | 53.07 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 52.59 | silver quality |
| neocortex | UBERON:0001950 | 52.53 | gold quality |
| right lobe of liver | UBERON:0001114 | 52.47 | gold quality |
| metanephros cortex | UBERON:0010533 | 52.35 | gold quality |
| caudate nucleus | UBERON:0001873 | 52.33 | gold quality |
| frontal cortex | UBERON:0001870 | 52.19 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 51.50 | gold quality |
| putamen | UBERON:0001874 | 51.49 | gold quality |
| oocyte | CL:0000023 | 51.47 | gold quality |
| cortical plate | UBERON:0005343 | 51.45 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 51.00 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 50.92 | gold quality |
| brain | UBERON:0000955 | 50.88 | gold quality |
| cerebral cortex | UBERON:0000956 | 50.88 | gold quality |
| Ammon’s horn | UBERON:0001954 | 50.73 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.96 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- FBXO35 gene had a ubiquitously low expression pattern in most human adult tissues. FBXO35 gene was found located in chromosome 3p21. (PMID:15040455)
- FBXW12 functions as an E3 ligase constituent to ubiquitinate and degrade IL-22R and that therapeutic FBXW12 inhibition may enhance IL-22 signaling and bolster mucosal host defense and infection containment. (PMID:26171402)
- FBXW12 gene is deleted in approximately ten percent of the epithelial ovarian cancer cases studied; such deletions comprised either the FBXW12 promoter or the mRNA-encoding region. (PMID:26617728)
Cross-species orthologs
21 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | wdr54 | ENSDARG00000010248 |
| danio_rerio | si:dkey-202c14.3 | ENSDARG00000096532 |
| danio_rerio | si:ch211-154o6.3 | ENSDARG00000099846 |
| mus_musculus | Fbxw21 | ENSMUSG00000047237 |
| mus_musculus | Fbxw13 | ENSMUSG00000049314 |
| mus_musculus | Fbxw28 | ENSMUSG00000054087 |
| mus_musculus | Fbxw26 | ENSMUSG00000059547 |
| mus_musculus | Fbxw20 | ENSMUSG00000061701 |
| mus_musculus | Fbxw24 | ENSMUSG00000062275 |
| mus_musculus | Fbxw22 | ENSMUSG00000070324 |
| mus_musculus | Fbxw18 | ENSMUSG00000074059 |
| mus_musculus | Fbxw15 | ENSMUSG00000074060 |
| mus_musculus | Fbxw19 | ENSMUSG00000074061 |
| mus_musculus | Fbxw16 | ENSMUSG00000074062 |
| mus_musculus | Fbxw25 | ENSMUSG00000094992 |
| mus_musculus | Fbxw27 | ENSMUSG00000104614 |
| mus_musculus | Fbxw14 | ENSMUSG00000105589 |
| rattus_norvegicus | Fbxw12 | ENSRNOG00000020720 |
| drosophila_melanogaster | WDY | FBGN0267449 |
| caenorhabditis_elegans | WBGENE00004744 | |
| caenorhabditis_elegans | WBGENE00004767 |
Paralogs (14): WDR54 (ENSG00000005448), FBXW11 (ENSG00000072803), FBXW7 (ENSG00000109670), TRAF7 (ENSG00000131653), FBXW9 (ENSG00000132004), FBXO36 (ENSG00000153832), WDR64 (ENSG00000162843), BTRC (ENSG00000166167), WDR49 (ENSG00000174776), FBXW8 (ENSG00000174989), PAAF1 (ENSG00000175575), WDR86 (ENSG00000187260), FBXO16 (ENSG00000214050), EFCAB8 (ENSG00000215529)
Protein
Protein identifiers
F-box/WD repeat-containing protein 12 — Q6X9E4 (reviewed: Q6X9E4)
Alternative names: F-box and WD-40 domain-containing protein 12, F-box only protein 35
All UniProt accessions (2): C9JK86, Q6X9E4
UniProt curated annotations — full annotation on UniProt →
Function. Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. Promotes degradation of interleukin-22 receptor subunit IL22RA1 in resting and IL22-stimulated conditions by facilitating its ubiquitination. Functions as a cell growth suppressor.
Subunit / interactions. Interacts with SKP1. Interacts with CUL1. Interacts with IL22RA1.
Tissue specificity. Ubiquitously expressed.
Pathway. Protein modification; protein ubiquitination.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6X9E4-1 | 1 | yes |
| Q6X9E4-2 | 2 | |
| Q6X9E4-3 | 3 |
RefSeq proteins (3): NP_001153399, NP_001153401, NP_996985* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001810 | F-box_dom | Domain |
| IPR011044 | Quino_amine_DH_bsu | Homologous_superfamily |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR036047 | F-box-like_dom_sf | Homologous_superfamily |
| IPR052121 | F-box_SCF_Substrate_Recog | Family |
Pfam: PF12937
UniProt features (17 total): repeat 8, sequence variant 3, splice variant 2, sequence conflict 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6X9E4-F1 | 88.24 | 0.61 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-8951664 | Neddylation |
| R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation |
MSigDB gene sets: 57 (showing top):
REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION, REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_SCF_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS, AFFAR_YY1_TARGETS_DN, SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, GOBP_PROTEIN_CATABOLIC_PROCESS, GOCC_SCF_UBIQUITIN_LIGASE_COMPLEX, GOCC_TRANSFERASE_COMPLEX, MARSON_BOUND_BY_FOXP3_STIMULATED, GOBP_PROTEOLYSIS, GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX
GO Biological Process (1): protein ubiquitination (GO:0016567)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): cytosol (GO:0005829), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
| Class I MHC mediated antigen processing & presentation | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| protein modification by small protein conjugation | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
792 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FBXW12 | SKP1 | P34991 | 656 |
| FBXW12 | CUL1 | Q13616 | 633 |
| FBXW12 | FBXW9 | Q5XUX1 | 544 |
| FBXW12 | FBXW4 | P57775 | 488 |
| FBXW12 | FBXW10 | Q5XX13 | 475 |
| FBXW12 | FBXL13 | Q8NEE6 | 475 |
| FBXW12 | FBXW5 | Q969U6 | 463 |
| FBXW12 | FBXW2 | Q9UKT8 | 460 |
| FBXW12 | TAS2R9 | Q9NYW1 | 458 |
| FBXW12 | FBXW8 | Q8N3Y1 | 454 |
| FBXW12 | FBXW11 | Q9UKB1 | 448 |
| FBXW12 | C5orf52 | A6NGY3 | 448 |
| FBXW12 | CFAP97D1 | B2RV13 | 439 |
| FBXW12 | FBXO41 | Q8TF61 | 423 |
| FBXW12 | FBXO34 | Q9NWN3 | 400 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FBXW12 | RUNX1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (14): IL22RA1 (Affinity Capture-Western), SKP1 (Affinity Capture-Western), IL22RA1 (Biochemical Activity), FBXW12 (Affinity Capture-MS), FBXW12 (Synthetic Lethality), GET4 (Affinity Capture-MS), RUNX2 (Affinity Capture-MS), FAM63A (Affinity Capture-MS), RUNX1 (Affinity Capture-MS), RUNX3 (Affinity Capture-MS), CBFB (Affinity Capture-MS), MAP3K7 (Affinity Capture-Western), FBXW12 (Co-fractionation), FBXW12 (Co-fractionation)
ESM2 similar proteins: A0A1L8GXY4, A4D1P6, A8XSV3, B0JZ65, B0R160, B0WYR6, E9Q7R9, F1REV3, F6S215, O00443, O65418, P50748, Q09178, Q12769, Q17I16, Q19317, Q2TAW0, Q3MHH2, Q402B2, Q4V9P9, Q5R6T6, Q5RAY1, Q5RB52, Q5RE88, Q5ZJY3, Q5ZL79, Q5ZLL7, Q6DTM3, Q6GM71, Q6INI5, Q6P996, Q6X9E4, Q6ZQQ6, Q7TMQ7, Q86XI2, Q8BJW5, Q8BMQ2, Q8C3Y4, Q8K3E5, Q8N157
Diamond homologs: A1C7E4, A1DHW6, A2QCU8, B0XTS1, B6Q4Z5, B8M7Q5, B8NGT5, D4AM37, D4D8P3, L7N1X6, P87053, Q0CY32, Q2UFN8, Q4X0A9, Q6X9E4
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| FBXW12 | “down-regulates quantity by destabilization” | IL22RA1 | binding |
| FBXW12 | “up-regulates activity” | “Cullin 1-RBX1-Skp1” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
72 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 60 |
| Likely benign | 11 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1613 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:48373641:G:GT | donor_gain | 1.0000 |
| 3:48373642:A:T | donor_gain | 1.0000 |
| 3:48373690:G:GG | donor_gain | 1.0000 |
| 3:48381676:T:G | acceptor_gain | 1.0000 |
| 3:48381678:T:G | acceptor_gain | 1.0000 |
| 3:48381690:A:AG | acceptor_gain | 1.0000 |
| 3:48381690:AT:A | acceptor_gain | 1.0000 |
| 3:48381691:T:G | acceptor_gain | 1.0000 |
| 3:48373306:A:AG | acceptor_gain | 0.9900 |
| 3:48373307:G:GG | acceptor_gain | 0.9900 |
| 3:48373614:G:GT | donor_gain | 0.9900 |
| 3:48373729:GAACA:G | donor_gain | 0.9900 |
| 3:48381672:T:G | acceptor_gain | 0.9900 |
| 3:48381674:T:G | acceptor_gain | 0.9900 |
| 3:48381689:C:G | acceptor_gain | 0.9900 |
| 3:48373711:GGTA:G | donor_gain | 0.9800 |
| 3:48375352:A:AG | acceptor_gain | 0.9800 |
| 3:48375353:G:GG | acceptor_gain | 0.9800 |
| 3:48378315:AG:A | acceptor_gain | 0.9800 |
| 3:48378316:GG:G | acceptor_gain | 0.9800 |
| 3:48381660:T:G | acceptor_gain | 0.9800 |
| 3:48381675:ATAT:A | acceptor_gain | 0.9800 |
| 3:48381677:ATGT:A | acceptor_gain | 0.9800 |
| 3:48381678:T:TA | acceptor_gain | 0.9800 |
| 3:48381682:C:CA | acceptor_gain | 0.9800 |
| 3:48381688:A:AG | acceptor_gain | 0.9800 |
| 3:48381688:ACAT:A | acceptor_gain | 0.9800 |
| 3:48381699:GC:G | acceptor_gain | 0.9800 |
| 3:48381789:A:AG | acceptor_gain | 0.9800 |
| 3:48381790:G:GG | acceptor_gain | 0.9800 |
AlphaMissense
3081 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:48380792:T:A | W289R | 0.989 |
| 3:48380792:T:C | W289R | 0.989 |
| 3:48381717:T:C | F335L | 0.985 |
| 3:48381719:C:A | F335L | 0.985 |
| 3:48381719:C:G | F335L | 0.985 |
| 3:48378335:A:C | S142R | 0.984 |
| 3:48378337:C:A | S142R | 0.984 |
| 3:48378337:C:G | S142R | 0.984 |
| 3:48378428:T:A | W173R | 0.983 |
| 3:48378428:T:C | W173R | 0.983 |
| 3:48373311:T:A | W32R | 0.980 |
| 3:48373311:T:C | W32R | 0.980 |
| 3:48379517:T:A | W245R | 0.976 |
| 3:48379517:T:C | W245R | 0.976 |
| 3:48380794:G:C | W289C | 0.976 |
| 3:48380794:G:T | W289C | 0.976 |
| 3:48382008:G:C | W406C | 0.976 |
| 3:48382008:G:T | W406C | 0.976 |
| 3:48382006:T:A | W406R | 0.974 |
| 3:48382006:T:C | W406R | 0.974 |
| 3:48394591:A:C | S443R | 0.971 |
| 3:48394593:C:A | S443R | 0.971 |
| 3:48394593:C:G | S443R | 0.971 |
| 3:48378329:T:A | W140R | 0.970 |
| 3:48378329:T:C | W140R | 0.970 |
| 3:48381802:T:C | L363S | 0.970 |
| 3:48373341:T:A | W42R | 0.969 |
| 3:48373341:T:C | W42R | 0.969 |
| 3:48378430:G:C | W173C | 0.968 |
| 3:48378430:G:T | W173C | 0.968 |
dbSNP variants (sampled 300 via entrez): RS1000033582 (3:48380690 T>C), RS1000089258 (3:48388822 C>G), RS1000284416 (3:48374019 T>C), RS1000284554 (3:48372032 A>C,G), RS1000378133 (3:48394148 T>C), RS1000410751 (3:48393916 C>T), RS1000831832 (3:48370818 TTTG>T,TTTGTTG), RS1000989204 (3:48394721 T>G), RS1001040493 (3:48378454 G>A), RS1001050639 (3:48381031 T>G), RS1001143396 (3:48381255 C>G), RS1001327616 (3:48390468 G>A), RS1001406681 (3:48387710 G>A,C,T), RS1001770321 (3:48371150 T>C), RS1002297357 (3:48377545 G>T)
Disease associations
OMIM: gene MIM:609075 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010698_80 | Subcortical volume (min-P) | 3.000000e-24 |
| GCST010699_110 | Brain morphology (min-P) | 4.000000e-08 |
| GCST010701_52 | Cortical surface area (MOSTest) | 1.000000e-16 |
| GCST010702_36 | Subcortical volume (MOSTest) | 1.000000e-10 |
| GCST010703_262 | Brain morphology (MOSTest) | 2.000000e-13 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs17080138 | FBXW12 | 0.00 | 0 |
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| propionaldehyde | decreases expression | 1 |
| lead acetate | affects cotreatment, increases expression | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| zinc protoporphyrin | affects cotreatment, increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Formaldehyde | increases expression | 1 |
| Glucose | increases expression | 1 |
| Rotenone | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.